Literature DB >> 9034830

Compromised blood-nerve barrier, astrogliosis, and myelin disruption in optic nerves during fatal murine cerebral malaria.

N Ma1, M C Madigan, T Chan-Ling, N H Hunt.   

Abstract

We examined the optic nerve, as an analogous tissue to brain white matter, to assess possible relationships between changes in the blood-nerve barrier, axonal integrity, and astrocyte morphology in the central nervous system during fatal murine cerebral malaria (FMCM). In the FMCM model, namely, CBA mice infected with Plasmodium berghei ANKA, neurological symptoms begin around day 5 post-inoculation (p.i.) and mice become increasingly ill by day 7 p.i., at which time they lapse into coma and die. Using intravascular perfusion with horseradish peroxidase combined with light and electron microscopy, and GFAP immunohistochemistry, the optic nerves in malaria-infected mice were found to display i) breakdown of the blood-nerve barrier, detectable as early as day 3 p.i. (about 2 days before the onset of neurological symptoms) increasing to peak severity by day 7 p.i.; ii) monocytosis, vascular congestion, and monocyte adherence to the endothelium in the microvasculature during the later stages of the disease process; iii) an increased incidence of patchy axonal demyelination and degeneration, mostly associated with vascular changes and astrogliosis, beginning at day 5 p.i. and more evident by day 7 p.i.; and iv) an increased intensity of GFAP immunostaining, detectable from day 3 p.i. and peaking at day 7 p.i. These optic nerve changes were always seen in the infected individuals, though they varied in intensity. The temporal and anatomical coincidence between the compromised blood-nerve barrier, monocyte adherence to the vascular endothelium, astrocyte changes, neuronal degeneration, and demyelination in the optic nerve in FMCM suggests that these factors are mechanistically inter-related. These findings are consistent with the proposed immunopathological nature of FMCM and provide further evidence for the pivotal role of the CNS microvasculature in the disease process. This is the first investigation of involvement of the optic nerve in FMCM and the first demonstration, to our knowledge, of loss of axonal viability in this condition in any CNS tissue. The observed demyelination is consistent with reports by other workers on such changes in the brain in human cerebral malaria.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9034830     DOI: 10.1002/(sici)1098-1136(199702)19:2<135::aid-glia5>3.0.co;2-#

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  15 in total

1.  Expression of Tim-1 and Tim-3 in Plasmodium berghei ANKA infection.

Authors:  Bo Huang; Man Liu; Shiguang Huang; Bin Wu; Hong Guo; Xin-Zhuan Su; Fangli Lu
Journal:  Parasitol Res       Date:  2013-05-08       Impact factor: 2.289

2.  In the eye of experimental cerebral malaria.

Authors:  Raman Saggu; Dorothée Faille; Georges E Grau; Patrick J Cozzone; Angèle Viola
Journal:  Am J Pathol       Date:  2011-07-08       Impact factor: 4.307

3.  Possible role of heme oxygenase-1 and prostaglandins in the pathogenesis of cerebral malaria: heme oxygenase-1 induction by prostaglandin D(2) and metabolite by a human astrocyte cell line.

Authors:  Jiraporn Kuesap; Kesara Na-Bangchang
Journal:  Korean J Parasitol       Date:  2010-03-17       Impact factor: 1.341

4.  Tumor necrosis factor-alpha expression in the brain during fatal murine cerebral malaria: evidence for production by microglia and astrocytes.

Authors:  I M Medana; N H Hunt; G Chaudhri
Journal:  Am J Pathol       Date:  1997-04       Impact factor: 4.307

5.  Persistent cognitive and motor deficits after successful antimalarial treatment in murine cerebral malaria.

Authors:  Minxian Dai; Sandra E Reznik; David C Spray; Louis M Weiss; Herbert B Tanowitz; Maria Gulinello; Mahalia S Desruisseaux
Journal:  Microbes Infect       Date:  2010-08-26       Impact factor: 2.700

6.  Evidence for multiple pathologic and protective mechanisms of murine cerebral malaria.

Authors:  V M Jennings; A A Lal; R L Hunter
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

Review 7.  Glial activation and matrix metalloproteinase release in cerebral malaria.

Authors:  A Szklarczyk; M Stins; E A Milward; H Ryu; C Fitzsimmons; D Sullivan; K Conant
Journal:  J Neurovirol       Date:  2007       Impact factor: 2.643

8.  Cerebrospinal fluid cytokine levels and cognitive impairment in cerebral malaria.

Authors:  Chandy C John; Angela Panoskaltsis-Mortari; Robert O Opoka; Gregory S Park; Paul J Orchard; Anne M Jurek; Richard Idro; Justus Byarugaba; Michael J Boivin
Journal:  Am J Trop Med Hyg       Date:  2008-02       Impact factor: 2.345

Review 9.  Cerebral malaria: mysteries at the blood-brain barrier.

Authors:  Laurent Rénia; Shanshan Wu Howland; Carla Claser; Anne Charlotte Gruner; Rossarin Suwanarusk; Teck Hui Teo; Bruce Russell; Lisa F P Ng
Journal:  Virulence       Date:  2012-03-01       Impact factor: 5.882

10.  Erythropoietin treatment alleviates ultrastructural myelin changes induced by murine cerebral malaria.

Authors:  Casper Hempel; Poul Hyttel; Trine Staalsø; Jens R Nyengaard; Jørgen A L Kurtzhals
Journal:  Malar J       Date:  2012-06-28       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.